Millennium Management’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
Other funds holding SER
BC
WA
KP
Millennium Management's SER Position: Q2 2025 in Review
Millennium Management sold out of Serina Therapeutics (SER) in Q2 2025, closing a stake of 10,721 shares — an estimated $60.8K sold.
Millennium Management first reported a position in SER in Q4 2018 and held it in 13 quarters. The position peaked at $296K in Q1 2019. 23 funds tracked by Wall St. Rank hold SER as of Q2 2025.
- Millennium Management reported no remaining Serina Therapeutics position as of Q2 2025 after selling out during the quarter.
- Millennium Management sold 10,721 Serina Therapeutics shares in Q2 2025, an estimated $60.8K.
- Millennium Management first reported a position in Serina Therapeutics in Q4 2018 and held it in 13 quarters.
- Millennium Management's Serina Therapeutics position peaked at $296K in Q1 2019.
- 23 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2025.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.